Pseudomonas aeruginosa pilin activates the inflammasome

Cellular Microbiology

Volumn 13, Issue 3, 2011, Pages 388-401

  Lindestam Arlehamn, Cecilia S ^a   Evans, Tom J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CRYOPYRIN; FLAGELLIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PILIN; PROTEIN NLRC4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; MACROPHAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CASPASE 1; CYTOSKELETAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FIMBRIAE PROTEINS; FLAGELLIN; INFLAMMASOMES; INTERLEUKIN-1BETA; MACROPHAGES; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

EID: 79951485622     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2010.01541.x     Document Type: Article

References (55)

1. Agostini, L., Martinon, F., Burns, K., McDermott, M.F., Hawkins, P.N., and Tschopp, J. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325.
2. Andersen-Nissen, E., Smith, K.D., Strobe, K.L., Barrett, S.L., Cookson, B.T., Logan, S.M., and Aderem, A. (2005) Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 102: 9247-9252.
3. Arora, S.K., Dasgupta, N., Lory, S., and Ramphal, R. (2000) Identification of two distinct types of flagellar cap proteins, FliD, in Pseudomonas aeruginosa. Infect Immun 68: 1474-1479.
4. Auron, P.E., Webb, A.C., Rosenwasser, L.J., Mucci, S.F., Rich, A., Wolff, S.M., and Dinarello, C.A. (1984) Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 81: 7907-7911.
5. Bergsbaken, T., Fink, S.L., and Cookson, B.T. (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7: 99-109.
6. Bird, S., Zou, J., Wang, T., Munday, B., Cunningham, C., and Secombes, C.J. (2002) Evolution of interleukin-1beta. Cytokine Growth Factor Rev 13: 483-502.
7. Bitter, W. (2003) Secretins of Pseudomonas aeruginosa: large holes in the outer membrane. Arch Microbiol 179: 307-314.
8. Case, C.L., Shin, S., and Roy, C.R. (2009) Asc and Ipaf Inflammasomes direct distinct pathways for caspase-1 activation in response to Legionella pneumophila. Infect Immun 77: 1981-1991.
9. Choi, K.H., Kumar, A., and Schweizer, H.P. (2006) A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. J Microbiol Methods 64: 391-397.
10. Cornelis, G.R., and Van Gijsegem, F. (2000) Assembly and function of type III secretory systems. Annu Rev Microbiol 54: 735-774.
11. Craig, L., Pique, M.E., and Tainer, J.A. (2004) Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol 2: 363-378.
12. Dinarello, C.A. (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550.
13. Evans, T.J. (2009) Bacterial triggering of inflammation by intracellular sensors. Future Microbiol 4: 65-75.
14. Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.D., Ozoren, N., Jagirdar, R., etal. (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7: 576-582.
15. Franchi, L., Stoolman, J., Kanneganti, T.D., Verma, A., Ramphal, R., and Nunez, G. (2007) Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur J Immunol 37: 3030-3039.
16. Franchi, L., Eigenbrod, T., Munoz-Planillo, R., and Nunez, G. (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10: 241-247.
17. von Götz, F., Häussler, S., Jordan, D., Saravanamuthu, S.S., Wehmhöner, D., Strüssmann, A., etal. (2004) Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis. J Bacteriol 186: 3837-3847.
18. Hahn, H.P. (1997) The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa - a review. Gene 192: 99-108.
19. Hazes, B., Sastry, P.A., Hayakawa, K., Read, R.J., and Irvin, R.T. (2000) Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding. J Mol Biol 299: 1005-1017.
20. Hsu, L.C., Ali, S.R., McGillivray, S., Tseng, P.H., Mariathasan, S., Humke, E.W., etal. (2008) A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA 105: 7803-7808.
21. Johnson, S., Deane, J.E., and Lea, S.M. (2005) The type III needle and the damage done. Curr Opin Struct Biol 15: 700-707.
22. Kanneganti, T.D., Lamkanfi, M., Kim, Y.G., Chen, G., Park, J.H., Franchi, L., etal. (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26: 433-443.
23. Kus, J., Tullis, E., Cvitkovitch, D., and Burrows, L. (2004) Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology 150: 1315.
24. Lightfield, K.L., Persson, J., Brubaker, S.W., Witte, C.E., von Moltke, J., Dunipace, E.A., etal. (2008) Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat Immunol 9: 1171-1178.
25. Lindestam Arlehamn, C.S., Petrilli, V., Gross, O., Tschopp, J., and Evans, T.J. (2010) The role of potassium in inflammasome activation by bacteria. J Biol Chem 285: 10508-10518.
26. Liu, P.V. (1966) The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease. J Infect Dis 116: 112-116.
27. Marathe, R., and Dinesh-Kumar, S.P. (2003) Plant defense: one post, multiple guards?! Mol Cell 11: 284-286.
28. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., etal. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218.
29. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., etal. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
30. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
31. Martinon, F., Mayor, A., and Tschopp, J. (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27: 229-265.
32. Mattick, J.S. (2002) Type IV pili and twitching motility. Annu Rev Microbiol 56: 289-314.
33. Miao, E.A., Alpuche-Aranda, C.M., Dors, M., Clark, A.E., Bader, M.W., Miller, S.I., and Aderem, A. (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7: 569-575.
34. Miao, E.A., Ernst, R.K., Dors, M., Mao, D.P., and Aderem, A. (2008) Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci USA 105: 2562-2567.
35. Miao, E.A., Mao, D.P., Yudkovsky, N., Bonneau, R., Lorang, C.G., Warren, S.E., etal. (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA 107: 3076-3080.
36. Murray, T.S., and Kazmierczak, B.I. (2008) Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella. J Bacteriol 190: 2700-2708.
37. Muruve, D.A., Petrilli, V., Zaiss, A.K., White, L.R., Clark, S.A., Ross, P.J., etal. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103-107.
38. Neyt, C., and Cornelis, G.R. (1999) Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG. Mol Microbiol 33: 971-981.
39. O'Neill, L.A. (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 226: 10-18.
40. Perkins, D.N., Pappin, D.J.C., Creasy, D.M., and Cottrell, J.S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567.
41. Pier, G.B., and Ramphal, R. (2005) Pseudomonas aeruginosa. In Principles and Practice of Infectious Diseases, 6th edn. Mandell, G.L., Bennett, J.E., and Dolin, R. (eds). Philadelphia, PA: Elsevier Churchill Livingstone, pp. 2587-2615.
42. Proft, T., and Baker, E.N. (2009) Pili in Gram-negative and Gram-positive bacteria-structure, assembly and their role in disease. Cell Mol Life Sci 66: 613-635.
43. Sato, H., Frank, D.W., Hillard, C.J., Feix, J.B., Pankhaniya, R.R., Moriyama, K., etal. (2003) The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J 22: 2959-2969.
44. Sato, H., Feix, J.B., and Frank, D.W. (2006) Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU. Biochemistry (Mosc) 45: 10368-10375.
45. Sawa, T., Yahr, T.L., Ohara, M., Kurahashi, K., Gropper, M.A., Wiener-Kronish, J.P., and Frank, D.W. (1999) Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 5: 392-398.
46. Schroeder, T.H., Zaidi, T., and Pier, G.B. (2001) Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM (1) on epithelial cells. Infect Immun 69: 719-729.
47. Semmler, A.B., Whitchurch, C.B., and Mattick, J.S. (1999) A re-examination of twitching motility in Pseudomonas aeruginosa. Microbiology 145 (Part 10): 2863-2873.
48. Smedley, J.G., 3rd, Jewell, E., Roguskie, J., Horzempa, J., Syboldt, A., Stolz, D.B., and Castric, P. (2005) Influence of pilin glycosylation on Pseudomonas aeruginosa 1244 pilus function. Infect Immun 73: 7922-7931.
49. Sutterwala, F.S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G.S., Grant, E.P., etal. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.
50. Sutterwala, F.S., Mijares, L.A., Li, L., Ogura, Y., Kazmierczak, B.I., and Flavell, R.A. (2007) Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med 204: 3235-3245.
51. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., etal. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774.
52. Ting, J.P., Lovering, R.C., Alnemri, E.S., Bertin, J., Boss, J.M., Davis, B.K., etal. (2008) The NLR gene family: a standard nomenclature. Immunity 28: 285-287.
53. Vallis, A.J., Finck-Barbancon, V., Yahr, T.L., and Frank, D.W. (1999) Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun 67: 2040-2044.
54. Ye, Z., and Ting, J.P. (2008) NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20: 3-9.
55. Yu, H.B., and Finlay, B.B. (2008) The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 4: 198-208.